20201221 – CTA Approval BT-001 – EN
Month: December 2020
Transgene Announces Financial Calendar for 2021
20191217 Financial calendar 2021 EN
Transgene Announces Investor Meetings for January 2021
20201216 PR Investors Meeting agenda Jan 2021
Transgene to present Phase 1b/2 trial results of TG4001 in combination with avelumab in advanced HPV-positive cancers at ESMO IO 2020
20201203 – TG4001 mini oral prez ESMO IO EN
Transgene appoints Hedi Ben Brahim as Chairman and Chief Executive Officer
20201203 – Nomination Transgene – EN